Page 87 - IMO-2-2
P. 87

Innovative Medicines & Omics                                      Herbal drug among non-health professionals



            104. Abourashed EA, Ashrafi H. Regulatory challenges for herbal   frameworks for herbal products: Insights from India. J Clin
               medicines: The case for improved access and information   Pharm Ther. 2021;46(3):678-683.
               sharing. J Herb Med. 2020;25:100.
                                                                  doi: 10.1111/jcpt.13205
               doi: 10.1016/j.hermed.2020.100408
                                                               110. Uzoechi A, Maduka O. The relevance of traditional medicine
            105. Roberts DL, Harris M. Ethical marketing of herbal products:   in non-communicable disease management in Nigeria. Iran
               Balancing opportunity and consumer protection.  J  Public   Jour of Pub Helth. 2022;51:915-22.
               Health Policy. 2021;42(1):321-334.
                                                                  doi: 10.5603/CJ.a2015.0039
               doi: 10.1057/s41271-020-00278-3
                                                               111. NAFDAC  NIGERIA  Journey:  Some  Administrative
            106. Saleem M, Saleh M. Addressing the fragmentation of herbal   Guidelines. Available from: https://www.nafdacnigeria.org/
               medicine information: The role of collaborative research.   journey.html [Last accessed on 2024 Aug 29].
               J Herb Med. 2022;24:39-50.
                                                               112. World Health Organization.  WHO Guideline on Good
               doi: 10.1111/ijem.12345                            Agricultural and Collection Practices (GACP) for Medicinal
                                                                  Plants; 2021. Available from: https://www.who.int/
            107. Peltokoski  J,  Salmi  I. Role of  healthcare providers in
               promoting credible herbal medicine information.  Health   publications/i/item/good-agricultural-and-collection-
               Policy. 2019;123(6):587-594.                       practices-gacp-for-medicinal-plants
                                                               113. Wambebe C. Regulatory framework for local production
               doi: 10.1016/j.ctcp.2020.101293
                                                                  of medicines in Africa. Latin Am Carib Bull Med Aromat
            108. Okwu DE, Nduka JC. Herbal drug use in Nigeria: A focus on   Plants. 2009;8:1-6.
               consumer safety and regulatory challenges. J Pharm Pharm
               Sci. 2020;23(2):33-45.                          114. Zhang Y, Wang D. Integration of herbal medicine in
                                                                  contemporary  healthcare:  Regulatory  implications.
               doi: 10.4236/pp.2021.121003                        J Ethnopharm. 2022;284:114-120.
            109. Mendiratta T, Sharma A. Bridging the gap in regulatory      doi: 10.1016/j.ijmedinf.2021.104488














































            Volume 2 Issue 2 (2025)                         81                          doi: 10.36922/IMO025080012
   82   83   84   85   86   87   88   89   90   91   92